לברסט

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

LETROZOLE 2.5 MG

Tersedia dari:

RAFA LABORATORIES LTD

Kode ATC:

L02BG04

Bentuk farmasi:

FILM COATED TABLETS

Rute administrasi :

PER OS

Diproduksi oleh:

SIEGFRIED GENERICS ( MALTA) LTD

Kelompok Terapi:

LETROZOLE

Indikasi Terapi:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Tanggal Otorisasi:

2012-04-01